Skip to main content
  • Policy
    Get Involved
    Join BIOAction
    View Advocacy Toolkit
    Patient Advocacy
    Human Health
    Cost and Value of Biopharmaceuticals
    Antimicrobial Resistance
    Vaccines & Biodefense
    Drug Development & Review
    International
    Global Markets & Trade
    Multilateral Organizations
    Intellectual Property
    National Security
    Science & Regulatory
    All Policy
    Patient Advocacy

    Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.

  • Member
    Membership Options
    Become a BIO Member
    Member Directory
    Have a Voice
    Membership Eligibility
    Member Toolkit
    Benefits By Sector
    member health
    Human Health
    member startups
    Startups
    member non R&D
    Non-R&D Companies
    Member Savings
    BBS-Programs-vwr
    VWR, Part of Avantor
    75% off Lab Supplies
    Save with BIO
    Save with BIO
  • News & Insights
    Latest biotech news
    Popular blogs
    Events
    Policy
    BIO Statements
    Press Releases
    Letters, Testimony & Comments
    Amicus Briefs
    BIO Reports
    Industry Analysis Reports
    Biotech Jobs
    Economic Development Best Practices
    BIO Briefly
    Issue Briefs
    BIO.News
    I am BIO Podcast
    All News & Insights

    Sign up for the BIO.News Newsletter >

  • Events
    Event Portfolio
    Business Development
    Health
    International
    Professional Development
    Members Only
    All Events
    BIO International Convention

    June 22-25, 2026 | San Diego, CA

    Learn More
    BIO Investor Forum
    BIO Asia-Taiwan

    July 15-19, 2026
    Taipei, Taiwan

    BIO Patient & Health Advocacy Summit
    BIO Patient Advocacy Changemakers Event

    October 22-23, 2026
    Washington, D.C

    BIO Asia-Taiwan
    BIO Europe

    November 9-11, 2026
    Cologne, Germany

    BIO Webinars

    Explore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.

  • About
    About Us
    Learn about our priorities
    BIO Leadership
    Meet BIO's Senior Leadership and Board of Directors
    Biotech Basics
    Read about biotechnology
    Industry Recognition
    Get to know the outstanding people and companies BIO supports
    Careers @ BIO
    Explore job openings with BIO today
  • Resource Hub
    Latest Resources
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Content Hub
    Biotech News (BIO.News)
    BIO.News Newsletter
    I am BIO Podcast
    BIO Advocacy Toolkit
    Resources Hub
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Webinars
    BIO Microsites
    Clinical Trials: The Power of Participation
    Covid Vaccine Facts
  • Search Results
    Previously Searched
Logo
Logo
Home
Search
  • Policy
    Human HealthPatient AdvocacyInternationalIntellectual PropertyNational SecurityScience & RegulatoryAll Policies
  • Member
    Become a BIO MemberBenefits By Sector
    Human HealthStartupsNon-R&D Companies
    Member DirectoryHave a VoiceMembership EligibilitySavings
  • News & Insights
    Press ReleasesBio.News BlogLetters, Testimony & CommentsAmicus BriefsIndustry Analysis ReportsBiotech JobsEconomic Development Best PracticesIssue BriefsBIO.NewsVideosAll News & Insights
  • Events
    BIO International ConventionBIO Asia-TaiwanAll Events
  • About
    About UsBIO LeadershipBiotech BasicsIndustry RecognitionCareers @ BIO
  • Resource Hub
    Biotech News (BIO.News)BIO.News NewsletterI am BIO PodcastBIO Advocacy ToolkitBIO Early-Stage Resources HubBIO Professional DevelopmentBIO WebinarsClinical Trials: The Power of ParticipationCovid Vaccine Facts
Search Results
Previously Searched
Search Results
Previously Searched
3199 results found
Expand All
Apply All
3199 results found

Measles could kill more kids than COVID this year. Why?
Share
Bio.News  •  June 16, 2020
Before we take a deep dive into a story from yesterday about vaccines for preventable diseases, we want to celebrate yesterday's historic Supreme Court decision protecting LGBTQ employees from workplace discrimination. In its decision, the court ruled that gay and transgender individuals are protected against discrimination under Title VII of the Civil Rights Act of 1964. “As the fight against social injustice continues in communities across the country, yesterday’s Supreme Court ruling on LGBTQ protections came as a sliver of good news," said BIO's President and CEO Dr. Michelle McMurry-Heath. "BIO celebrates the court’s ruling especially in a month where pride and love for oneself should reign supreme. And BIO will continue fighting to ensure everyone has access to care, even in the wake of the Trump administration’s decision to roll back healthcare protections for transgender individuals. "The biotech community would not be what it is today without its diverse set of scientists, researchers, medical professionals, and employees, which bring invaluable experiences, perspectives, and voices in the fight to feed, fuel and heal for all.” For more information on BIO's campaign to accelerate gender, racial, ethnic, and LGBTQ representation on biotech company boards, in C-suites and in leadership positions, visit TheRightMixMatters.com. Now, here are around 650 words (3 minutes) on why we’re seeing a drastic decline in vaccination rates around the world (including the United States) and what we can do about it.
Read More

Merck
Share

Deep diving for COVID cures
Share
Bio.News  •  June 15, 2020
We start a new week with an announcement about one of BIO’s own: Dr. Clint Nesbitt, BIO’s Senior Director of Science and Regulatory Affairs for Food and Agriculture, has been named to the Task Force on Gene Editing in Animal Agriculture. The 11-person panel will develop recommendations for regulating the use of gene editing in animal agriculture with appropriate safeguards and procedures. Congratulations, Dr. Nesbitt! In other news, we have a new episode of the I AM BIO Podcast exploring the links between human health and the ocean, including a few COVID-19 breakthroughs discovered under the sea. We’ve also got the latest vaccine and Washington news. Here are 615 words, around 3 minutes.
Read More

Priority Review Voucher Programs
Share
Human Health, Rare Diseases  •  Toolkit  •  June 15, 2020
Priority review vouchers provide a powerful incentive to stimulate drug development for underserved diseases or conditions.
Read More

Best of BIO
Share
Policy

What biotech execs are saying about COVID-19
Share
Bio.News  •  June 12, 2020
What a week! BIO Digital was full of wisdom about how we can tackle the challenges ahead for our industry and world—from Dr. Fauci and our all-star COVID-19 panelists providing an update on vaccines and therapeutics, to Dr. Tony Coles’ powerful words about the need to CRISPR the systemic racism out of our social genome. We have a lot of work to do—but we know the biotech industry can handle it. To close out the week, we take a look at what biotech CEOs are saying about COVID-19 plus new legislation that would give ethanol producers more certainty about the future, in around 750 words, just under 4 minutes.
Read More

BIO’s Dr. Clint Nesbitt Named to APLU-AAVMC Task Force on Gene Editing in Animal Agriculture
Share
Press Release  •  June 11, 2020
Washington, D.C. (June 11, 2020) – Dr. Clint Nesbitt, Senior Director of Science and Regulatory Affairs for Food & Agriculture at the Biotechnology Innovation Organization (BIO), was named today to a Task Force on Gene Editing in Animal Agriculture. The Task Force is being led by the Association of Public and Land-grant Universities (APLU) and the Association of American Veterinary Medical Colleges (AAVMC). “We applaud the APLU and the AAVMC for launching this initiative that brings academic experts to the table,” said Dana O’Brien, BIO's Executive Vice President for Food & Agriculture. “We’re honored that Clint will be representing BIO among this impressive slate of individuals, some of the foremost animal science leaders in the world.” The 11-person panel is comprised of scientists and industry leaders who will develop recommendations for regulating the use of gene editing in animal agriculture with appropriate safeguards and procedures. “Animal biotechnology has enormous potential to address animal health and welfare, and numerous agricultural, environmental, humanitarian, and public health challenges, including helping to prevent and respond to zoonotic diseases such as COVID-19,” said Nesbitt. “New biotech methods like gene editing can make animals resistant to disease and enhance animal well-being. But an optimal regulatory system for animal biotechnology needs to address safety and oversight while paving the way for innovation to flourish,” Nesbitt added. In a letter sent last week to Congressional leaders, BIO joined with 27 members of the Council of State Bioscience Associations calling for legislative action to streamline the regulatory oversight of animal biotechnology. According to the APLU and the AAVMC, the task force was born out of a September 2019 symposium, “Gene Editing in Livestock: Looking to the Future,” which the two associations organized. During that event, 23 of the nation’s leading experts from academia, government,…
Read More

What the FDA Commissioner said about trials and collaboration
Share
Bio.News  •  June 11, 2020
It’s the last day of the BIO Digital education sessions, but the fun continues all day long at www.bio.org. Right now, we’re recapping what FDA Commissioner Dr. Stephen M. Hahn said during yesterday’s fireside chat and unpacking the latest news on when you might fly a biofuel-powered plane, in around 740 words, or 3 minutes, 40 seconds. We’ve expanded our list this week to include the BIO Digital and convention community, and we’ll be sending a morning and special evening edition each day through today. Like what you see? Opt in here to keep receiving this email after the event.
Read More

What the FDA Commissioner said about trials and collaboration
Share
Bio.News  •  June 11, 2020
It’s the last day of the BIO Digital education sessions, but the fun continues all day long at www.bio.org. Right now, we’re recapping what FDA Commissioner Dr. Stephen M. Hahn said during yesterday’s fireside chat and unpacking the latest news on when you might fly a biofuel-powered plane, in around 740 words, or 3 minutes, 40 seconds. We’ve expanded our list this week to include the BIO Digital and convention community, and we’ll be sending a morning and special evening edition each day through today. Like what you see? Opt in here to keep receiving this email after the event.
Read More

What the FDA Commissioner said about trials and collaboration
Share
Bio.News  •  June 11, 2020
It’s the last day of the BIO Digital education sessions, but the fun continues all day long at www.bio.org. Right now, we’re recapping what FDA Commissioner Dr. Stephen M. Hahn said during yesterday’s fireside chat and unpacking the latest news on when you might fly a biofuel-powered plane, in around 740 words, or 3 minutes, 40 seconds. We’ve expanded our list this week to include the BIO Digital and convention community, and we’ll be sending a morning and special evening edition each day through today. Like what you see? Opt in here to keep receiving this email after the event.
Read More

Pagination

  • First First page
  • Prev Previous page
  • …
  • 230
  • 231
  • 232
  • …
  • Next Next page
  • Last Last page
Biotechnology Innovation Organization
Explore BIO
Policy
Events
About
Industry Insights
Join Now
BIO PAC
For Members
Member Directory
BIO Policy Committees
Cost-Savings Program
BIO Events
BIO Investment and Growth Summit
BIO Partnering™ for Oncology
BIO International Convention
BIO Partnering™ at JPM Week
BIO Patient Advocacy Changemakers Events
1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 ・ 202-962-9200
© BIO 2025 All Rights Reserved
Privacy Policy
Terms of Use
Contact BIO